ClinicalTrials.gg
Sign In

Sarcoma, Alveolar Soft Part clinical trials

The registry lists 51 studies for Sarcoma, Alveolar Soft Part across more than 10 countries. 10 are recruiting or about to start. 24 of them are mainly about Sarcoma, Alveolar Soft Part (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Sarcoma, Alveolar Soft Part studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
25
Recruiting
9
Status unknown
6
Active, not recruiting
5
Terminated
4
Withdrawn
1

Phase

Phase 2
32
Phase 1
12
Phase 3
7
Early Phase 1
4

Where

United States
25
Canada
12
United Kingdom
9
Spain
6
France
6
Belgium
5

Who runs them

National Cancer Institute (NCI) (10) · European Organisation for Research and Treatment of Cancer - EORTC (8) · University of Calgary (2) · AHS Cancer Control Alberta (2) · Memorial Sloan Kettering Cancer Center (2) · AEterna Zentaris (1) · Institut Claudius Regaud (1) · University of Florida (1)

What is being tested here

Drugs under test in Sarcoma, Alveolar Soft Part studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Atezolizumab203
Anlotinib212
Pembrolizumab102
Selinexor102
Zimberelimab101
Zoledronic Acid101
Benmelstobart101
Catequentinib hydrochloride101
Dacarbazine111
Doxorubicin034

Drug classes tested here Immune checkpoint inhibitors 5 open · Tyrosine kinase inhibitors (TKIs) 2 open · Alkylating agents 1 open

Coming up

1phase 3 study under way
7studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7

Who these studies take

Of the 9 Sarcoma, Alveolar Soft Part studies recruiting now, 7 (78%) set no upper age limit and 1 (11%) stop at 75 or younger. 5 (56%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 9
AgeWomenMen
101 (11%)1 (11%)
189 (100%)9 (100%)
308 (89%)8 (89%)
408 (89%)8 (89%)
508 (89%)8 (89%)
658 (89%)8 (89%)
758 (89%)8 (89%)
858 (89%)8 (89%)

Across all 51 studies, recruiting or not: 14% stop at 75 or younger and 8% at 65; 53% take children; 2% are for women only and 2% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.